Clegg LE, Heerspink HJL, Penland RC, et al
Both Tesamorelin and Sermorelin occupy distinct positions within the broader landscape of GH-axis research tools and understanding how they relate to compounds like IGF-1 LR3 or dual GHRH/GHRP combinations provides a fuller picture for designing rigorous GH-optimization studies
The American Journal of Gastroenterology, 113 (1), 115123
Work published in Science Advances in 2025 found that GLP-1 acts on GABA neurons in the VTA to suppress dopamine signaling, functioning as a brake on the reward system [4]
Our attorneys collaborate with gastroenterologists and pharmacology experts to connect these medical results with regulatory timelines, identifying when each manufacturer first received safety data, how that information was reported to the FDA, and whether labeling was updated promptly
Management is guiding toward the end of 2025 having all of their weightloss customers covered by Medicare, insurance, or be on a cheaper version of semaglutide, perhaps copying HIMS with both branded and compound version, but still not getting sued because at least Novo Nordisk is making some money